Guizhi Fuling Capsules
Natural health product licensed in Canada
- Other names
- Guizhi Fuling Jiaonang
- Licence holder
- Wing Quon Enterprises Ltd.
- NPN or DIN-HM
- 80141343
- Status
- Active licence
- Licence date
- 28 May 2025
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Paeonia suffruticosa Source : Paeonia suffruticosa - Root Bark Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 240 mg | 24 mg | Not calculated |
| Cinnamomum aromaticum Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 240 mg | 24 mg | Not calculated |
| Wolfiporia extensa Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 48 mg | 4.8 mg | Not calculated |
| Paeonia lactiflora Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 240 mg | 24 mg | Not calculated |
| Prunus persica Source : Prunus persica - Graine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 240 mg | 24 mg | Not calculated |
| Wolfiporia extensa | 192 mg | Not calculated |
Non-medicinal ingredients
Gélatine, Stéarate de magnésium, Amidon de maïs, Talc
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 3 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Traditional Chinese medicine used to activate blood and resolve stasis. Traditional Chinese medicine used in women for amenorrhea, dysmenorrhea and postpartum lochia due to static blood obstructing collaterals, cystic hyperplasia of breast in female-due to static blood obstructing collaterals, cystic hyperplasia of breast in female-due to static blood obstructing collaterals, manifested as breast pain, breast lump and distension and oppression in the chest and the hypochondrium. Traditional Chinese medicine used in men for prostate hyperplasia due to stasis obstructing the bladder, manifested as unsmooth urination, thready or dribbling urine and distending pain in the lower abdomen.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80141343
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.